News
New research on using weight loss drugs for treating alcohol use disorder
Some weight loss and diabetes drugs that use GLP-1s have been found to help people stop drinking. Channel 5's GM released a statement saying the station and its parent company require employees "to adhere to the highest ethical standards.
The phase 2 ELAD study of Novo Nordisk's once-daily injectable GLP-1 agonist liraglutide in people with early-stage Alzheimer's has shown that the drug was able to reduce shrinking in the areas ...
News Medical on MSN2h
GLP-1 drugs linked to significant BMI reduction in children with severe obesityChildren who are living with severe obesity are more likely to experience a clinically relevant change in BMI when GLP-1 agonist drugs form part of their treatment, new research being presented at ...
Share on Pinterest Research is looking for ways to minimize muscle loss from GLP-1 drugs taken to treat ... said that “this study was helpful to show that some muscle can occur with ...
Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds over 72 weeks, ...
However, it is important to note that the study's cross-sectional design means these findings are correlational, not causal; the data do not show that these factors cause interest in GLP-1 use ...
The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...
Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after revenue more than doubled, and it raised full-year guidance. Revenue hit $ ...
Study presented at DDW ... trial design to support drug development. The study titled, "A Genetic Risk Score Associated with Nausea Resulting from GLP-1 Agonist Treatment: A Post-Hoc Analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results